 |
市場調查報告書
商品編碼
1357951
噬菌體治療市場：依目標細菌、依適應症、依給藥途徑、依配銷通路、依地區Bacteriophage Therapy Market, By Targeted Bacteria, Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, & Other), Route of Administration, Distribution Channel & Geography |
||||||
價格
簡介目錄
全球噬菌體治療市場預計到 2023 年將達到 12.809 億美元，預計在預測期內（2023-2030 年）年複合成長率為 3.7%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023年市場規模 | 12.809 億美元 |
| 實績資料 | 2018-2021 | 預測期 | 2023-2030 |
| 預測期年複合成長率 | 3.70% | 2030年市場規模預測 | 16.518 億美元 |
噬菌體療法全球市場佔有率(%)（依產品類型），2023 年
噬菌體，正式名稱為噬菌體，是一種僅殺死並選擇性靶向細菌的病毒。噬菌體是最常見的生物實體之一，可以有效對抗和消滅多重抗藥性細菌。當所有抗生素都無法對抗感染疾病時，噬菌體可以殺死引起感染疾病的細菌，使醫療相關人員能夠挽救生命。噬菌體被認為是抗生素的新治療方法替代品。在這種治療方法中，病毒將遺傳物質注入細菌中，並利用宿主的機制自行繁殖。這種噬菌體療法用於治療或預防患者體內的細菌感染。噬菌體療法在分子生物學和生物技術的研究領域也扮演著重要角色。這些要素正在擴大藥物研發的可能性。
市場動態
內部成長策略的增加（例如法規產品核可以擴大主要參與者的市場組合）預計將在預測期內推動市場成長。例如，2021年9月，Adaptive Phage Therapeutics, Inc. (APT)，一家臨床階段的生物技術公司，提供專門治療感染疾病的治療方法，宣布獲得額外的800萬美元獎勵，以繼續開發用於治療感染疾病的噬菌體療法（APT的PhageBankTM）。 Adaptive Phage Therapeutics, Inc. 很高興 APT 的噬菌體庫平台將幫助治療多種適應症的抗藥性感染疾病，並為國家的軍事人員創造潛在的挽救生命的治療方法。
本研究的主要特點
- 該研究報告對全球噬菌體治療市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和複合年度（年複合成長率）。
- 它還闡明了各個部門市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
- 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球噬菌體治療市場的主要企業。
- 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型經營團隊、市場擴張和行銷策略做出資訊的決策。
- 全球噬菌體治療市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
- 相關人員可以透過用於分析全球噬菌體治療市場的各種策略矩陣來促進決策。
目錄
第1章 調查目的和假設
- 這項研究的目的
- 假設
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 市場機會
- 影響分析
- 最近測試啟動
- 流行病學
- 合併、收購和合作
- 法規場景
- 主要進展
- PEST分析
第4章 全球噬菌體治療市場，COVID-19 的影響分析
- 經濟影響
- 新型冠狀病毒（COVID-19）的流行病學
- 對需求和供給的影響
第5章 全球噬菌體治療市場，依目標細菌，2018-2030
- 大腸桿菌
- 金黃色葡萄球菌
- 金黃色葡萄球菌
- 鏈球菌
- 銅綠假單胞菌
- 沙門氏菌
- 其他
第6章 全球噬菌體治療市場，依適應症分類，2018-2030
- 尿道感染
- 慢性中耳炎
- 拔牙
- 慢性潰瘍性大腸炎
- 骨感染疾病
- 傷口和皮膚感染疾病
- 囊性纖維化
- 其他
第7章 全球噬菌體治療市場，依給藥途徑，2018-2030
- 口服
- 局部的
- 胃腸外的
第8章 全球噬菌體治療市場（依配銷通路），2018-2030
- 醫院藥房
- 零售藥房
- 網路藥房
第9章 全球噬菌體治療市場，依地區，2018-2030
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 中東
- GCC
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第10章 競爭形勢
- 公司簡介
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Intralytix, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.
第11章章節
- 參考
- 調查方法
簡介目錄
Product Code: CMI2752
The global bacteriophage therapy market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 1,280.9 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 3.70% | 2030 Value Projection: | US$ 1,651.8 Mn |
Global Bacteriophage Therapy Market Share (%), By Product Type, 2023
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are one of the most common biological entities that can effectively fight and destroy multi-drug-resistant bacteria. When all antibiotics fail to work against an infection, the phages are able to kill the bacteria causing the infection, thus helping medical professionals save life. Bacteriophages are being considered as a new alternative to antibiotics. In this therapy, the viruses are used to inject their genetic material into bacteria and use their host machinery to multiply themselves. This phage therapy is used to treat or prevent bacterial infections in patients' bodies. Bacteriophage therapy also plays a significant role in the research fields of molecular biology and biotechnology. These factors enhance the potential scope for drug discovery.
Market Dynamics
The increasing organic growth strategies, such as product approval by regulatory authorities to expand key players market portfolio, are expected to drive market growth over the forecast period. For instance, in September 2021, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, announced that the Department of Defense (DoD), an executive branch department of the federal government of the U.S., had awarded the company an additional US$8 million for the continued development of bacteriophage therapies (APT's phage bankTM) for the treatment of infectious diseases. Adaptive Phage Therapeutics, Inc. said that it is thrilled APT's phage bank platform helps to treat drug-resistant infections across multiple indications that create potentially lifesaving therapies for the nation's service members.
Key features of the study:
- This report provides an in-depth analysis of the global bacteriophage therapy market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global bacteriophage therapy market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation, OPTIPHARM Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Bacteriophage Therapy Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriophage therapy market.
Detailed Segmentation:
- Global Bacteriophage Therapy Market, By Targeted Bacteria:
- Escherichia coli
- Staphylococcus aureus
- Streptococcus
- Pseudomonas aeruginosa
- Salmonella
- Others
- Global Bacteriophage Therapy Market, By Disease Indication:
- Urinary Tract Infections
- Chronic Otitis
- Dental Extraction
- Chronic Ulcerative Colitis
- Bone Infection
- Wound and Skin Infections
- Cystic Fibrosis
- Others
- Global Bacteriophage Therapy Market, By Route of Administration:
- Oral
- Topical
- Parenteral
- Global Bacteriophage Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Bacteriophage Therapy Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd.
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH.
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc.
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd.
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Targeted Bacteria
- Market Snippet, By Disease Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Bacteriophage Therapy Market, - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Bacteriophage Therapy Market, By Targeted Bacteria, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Streptococcus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Salmonella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
6. Global Bacteriophage Therapy Market, By Disease Indication, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Chronic Otitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Dental Extraction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Chronic Ulcerative Colitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Bone Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Wound and Skin Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
7. Global Bacteriophage Therapy Market, By Route of Administration, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
8. Global Bacteriophage Therapy Market, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
9. Global Bacteriophage Therapy Market, By Region, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Armata Pharmaceuticals, Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Eliava Biopreparations Ltd
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Intralytix, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.
11. Section
- References
- Research Methodology
- About us and Sales Contact
